JP2024509282A5 - - Google Patents
Info
- Publication number
- JP2024509282A5 JP2024509282A5 JP2023555333A JP2023555333A JP2024509282A5 JP 2024509282 A5 JP2024509282 A5 JP 2024509282A5 JP 2023555333 A JP2023555333 A JP 2023555333A JP 2023555333 A JP2023555333 A JP 2023555333A JP 2024509282 A5 JP2024509282 A5 JP 2024509282A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- group
- substituted
- alkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159383P | 2021-03-10 | 2021-03-10 | |
| US63/159,383 | 2021-03-10 | ||
| PCT/US2022/019658 WO2022192478A1 (en) | 2021-03-10 | 2022-03-10 | Bifunctional degraders of galactose-deficient immunoglobulins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509282A JP2024509282A (ja) | 2024-02-29 |
| JP2024509282A5 true JP2024509282A5 (https=) | 2025-03-19 |
Family
ID=83227063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555333A Pending JP2024509282A (ja) | 2021-03-10 | 2022-03-10 | ガラクトース欠損免疫グロブリンの二官能性分解剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240309114A1 (https=) |
| EP (1) | EP4304579A1 (https=) |
| JP (1) | JP2024509282A (https=) |
| KR (1) | KR20230154900A (https=) |
| CN (1) | CN116997337A (https=) |
| AU (1) | AU2022232620A1 (https=) |
| BR (1) | BR112023017702A2 (https=) |
| CA (1) | CA3211335A1 (https=) |
| IL (1) | IL305665A (https=) |
| MX (1) | MX2023010424A (https=) |
| WO (1) | WO2022192478A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023013274A (es) * | 2021-05-17 | 2023-11-30 | Biohaven Therapeutics Ltd | Composiciones que incluyen potenciadores de tratamientos conjugados. |
| EP4370157A1 (en) | 2021-07-14 | 2024-05-22 | Lycia Therapeutics, Inc. | Asgpr cell surface receptor binding compounds and conjugates |
| WO2024228935A1 (en) * | 2023-04-29 | 2024-11-07 | Biohaven Therapeutics Ltd. | Bifunctional degraders of galactose-deficient immunoglobulins |
| WO2026083257A1 (en) | 2024-10-14 | 2026-04-23 | Biohaven Therapeutics Ltd. | Antigen-specific degraders of immunoglobulin a and their uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8440191B2 (en) * | 2005-11-18 | 2013-05-14 | Tufts Medical Center | Clearance of abnormal IGA1 in IGA1 deposition diseases |
| PL2991683T3 (pl) * | 2013-05-02 | 2020-03-31 | Glykos Finland Oy | Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem |
| SG11201606761RA (en) * | 2014-02-21 | 2016-09-29 | Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto | Glycotargeting therapeutics |
| PL3145934T3 (pl) * | 2014-05-19 | 2021-08-16 | Pfizer Inc. | Podstawione związki 6,8-dioksabicyklo[3.2.1]oktano-2,3-diolu jako środki kierujące do ASGPR |
| EP3773727A4 (en) * | 2018-04-09 | 2022-05-04 | Yale University | BIFUNCTIONAL SMALL MOLECULES TO TARGETING THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS |
-
2022
- 2022-03-10 WO PCT/US2022/019658 patent/WO2022192478A1/en not_active Ceased
- 2022-03-10 BR BR112023017702A patent/BR112023017702A2/pt unknown
- 2022-03-10 EP EP22767951.1A patent/EP4304579A1/en active Pending
- 2022-03-10 CA CA3211335A patent/CA3211335A1/en active Pending
- 2022-03-10 JP JP2023555333A patent/JP2024509282A/ja active Pending
- 2022-03-10 MX MX2023010424A patent/MX2023010424A/es unknown
- 2022-03-10 KR KR1020237033102A patent/KR20230154900A/ko active Pending
- 2022-03-10 AU AU2022232620A patent/AU2022232620A1/en active Pending
- 2022-03-10 CN CN202280020292.8A patent/CN116997337A/zh active Pending
- 2022-03-10 US US18/548,113 patent/US20240309114A1/en active Pending
- 2022-03-10 IL IL305665A patent/IL305665A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509282A5 (https=) | ||
| CN102227442B (zh) | Sars冠状病毒的细胞毒性t细胞表位肽及其用途 | |
| JP5537431B2 (ja) | ウイルス融合のインヒビターのコレステロール誘導体 | |
| TWI839055B (zh) | 聚乙二醇化的藥物－連接劑及其中間體 | |
| Frisch et al. | Synthesis of short polyoxyethylene-based heterobifunctional cross-linking reagents. Application to the coupling of peptides to liposomes | |
| SA518391996B1 (ar) | نظائر عامل النمو الجلدي شبيه مجال أ ببدائل حمض دهني | |
| CN117915956A (zh) | M6pr细胞表面受体结合化合物和缀合物 | |
| CZ20021990A3 (cs) | Amfifilní polymery a polypeptidové konjugáty je obsahující | |
| JP2021513990A (ja) | 疎水性アウリスタチンｆ化合物およびそのコンジュゲート | |
| WO2000059932A1 (fr) | Peptides se liant a l'hemagglutinine du virus de la grippe | |
| JP2024509282A (ja) | ガラクトース欠損免疫グロブリンの二官能性分解剤 | |
| Zhuang et al. | Robo4 vaccines induce antibodies that retard tumor growth | |
| JP7733664B2 (ja) | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 | |
| CA3132994A1 (en) | Tlr4 and tlr7 ligand formulations as vaccine adjuvants | |
| CN102232083B (zh) | 禽流感疫苗 | |
| CN117355340A (zh) | 缀合物及其制备方法和用途 | |
| JP2021523109A (ja) | 老化細胞によって引き起こされるかまたは媒介される状態の臨床管理における使用のためおよびがんを治療するための、Ｂｃｌファミリーアンタゴニストであるホスホリジン | |
| JPH04506666A (ja) | ワクチンアジュバントとしてのｌｆａ―３ | |
| WO2012050193A1 (ja) | エボラウイルスリポソームワクチン | |
| JP5930967B2 (ja) | Ｃ型肝炎ウイルスリポソームワクチン | |
| WO2014119753A4 (ja) | マイオスタチン阻害ペプチド | |
| JP7339285B2 (ja) | Ｔｌｒ７ペプチドコンジュゲート | |
| EP4387660A1 (en) | Thermostable lipid nanoparticle and methods of use thereof | |
| EP3568409A1 (en) | An agent for promoting angiogenesis and methods and uses thereof | |
| CA3171449C (en) | Coronavirus therapeutics and treatment methods |